Thiazolidinediones, alpha-glucosidase inhibitors, meglitinides, sulfonylureas, and hepatocellular carcinoma risk: A meta-analysis
Ashwini Arvind, Zoe Memel, Lisa Philpotts, Hui Zheng, Kathleen E. Corey, Tracey G. Simon
Topics & Concepts
MedicineInternal medicineHepatocellular carcinomaIncidence (geometry)Odds ratioThiazolidinedioneMeta-analysisConfidence intervalDiabetes mellitusGastroenterologyHazard ratioRelative riskType 2 diabetesEndocrinologyOpticsPhysicsMetabolism, Diabetes, and CancerCancer, Lipids, and MetabolismLiver Disease Diagnosis and Treatment